Literature DB >> 24616007

Divergence of P53, PTEN, PI3K, Akt and mTOR expression in tonsillar cancer.

Sang Hoon Chun1, Chan-Kwon Jung, Hye Sung Won, Jin-Hyoung Kang, Yeon-Sil Kim, Min-Sik Kim.   

Abstract

BACKGROUND: The purpose of this study was to investigate expression differences of p53, PTEN, PI3K, Akt and mTOR according to the human papillomavirus (HPV) infection and to evaluate clinical significance as prognostic markers in patients with locally advanced tonsillar cancer.
METHODS: Sixty-five patients were reviewed. Tissue microarrays were prepared from surgical specimens and stained with antibodies against p53, PTEN, PIK3CA, Akt and mTOR.
RESULTS: Twenty-six patients were HPV-positive. Expression of P53 as well as PIK3CA, Akt and mTOR were not significantly different between the 2 groups. However, total PTEN (nuclear and cytoplasmic PTEN) expression was significantly frequent in HPV-positive group. Both overall survival (OS) and disease-free survival (DFS) were significantly different between the 2 groups. Nuclear PTEN expression in the cancer area and pathological nodal stage were significantly correlated with DFS.
CONCLUSION: Our study suggests that the presence of PTEN expression with predisposition to nucleus more frequently observed in HPV-positive tonsillar cancers are significantly associated with favorable survival outcome, independent of activated PI3K/Akt/mTOR cell survival pathway.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  P53; PI3K/Akt/mTOR pathway; PTEN; human papillomavirus (HPV); tonsillar cancer

Mesh:

Substances:

Year:  2014        PMID: 24616007     DOI: 10.1002/hed.23643

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  6 in total

1.  PTEN loss is associated with resistance to cetuximab in patients with head and neck squamous cell carcinoma.

Authors:  Nnamdi Eze; Ju-Whei Lee; Dong-Hua Yang; Fang Zhu; Veronique Neumeister; Teresa Sandoval-Schaefer; Ranee Mehra; John A Ridge; Arlene Forastiere; Christine H Chung; Barbara Burtness
Journal:  Oral Oncol       Date:  2019-03-04       Impact factor: 5.337

2.  A proportion of primary squamous cell carcinomas of the parotid gland harbour high-risk human papillomavirus.

Authors:  Bin Xu; Lu Wang; Laetitia Borsu; Ronald Ghossein; Nora Katabi; Ian Ganly; Snjezana Dogan
Journal:  Histopathology       Date:  2016-08-23       Impact factor: 5.087

3.  β-elemene induced anticancer effect in bladder cancer through upregulation of PTEN and suppression of AKT phosphorylation.

Authors:  Bo Cai; Limin Ma; Shaojun Nong; You Wu; Xin Guo; Jinxian Pu
Journal:  Oncol Lett       Date:  2018-09-05       Impact factor: 2.967

Review 4.  Biomarker driven treatment of head and neck squamous cell cancer.

Authors:  Nnamdi Eze; Ying-Chun Lo; Barbara Burtness
Journal:  Cancers Head Neck       Date:  2017-08-29

5.  Knockdown of Forkhead box A1 suppresses the tumorigenesis and progression of human colon cancer cells through regulating the phosphatase and tensin homolog/Akt pathway.

Authors:  Jie Pan; Zongbin Xu; Meifang Xu; Xiaoyan Lin; Bingqiang Lin; Mengxin Lin
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

6.  Comparison of PI3K Pathway in HPV-Associated Oropharyngeal Cancer With and Without Tobacco Exposure.

Authors:  Si-Young Kiessling; Martina Anja Broglie; Alex Soltermann; Gerhard Frank Huber; Sandro Johannes Stoeckli
Journal:  Laryngoscope Investig Otolaryngol       Date:  2018-08-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.